Genetic News and Research

RSS

New collaboration may allow researchers to develop potential gene therapies for pediatric diseases

A new collaboration between Seattle Children's Research Institute and bluebird bio, Inc., a biotechnology company based in Cambridge, Mass. and Seattle, will allow researchers to develop potentially transformative gene therapies for severe genetic and rare pediatric diseases. The collaboration supports pediatric researchers in Seattle who will work with bluebird bio scientists and the company's gene editing technology to research potential cures for genetic pediatric diseases.

11 Sep 2015

Research: Cancer preventative surgery may not be necessary in the future

Surgery to remove the breasts of women at increased risk of developing breast cancer may not be necessary in the future, according to research published in EBioMedicine. Two new studies looking at the effect the menstrual cycle has on the development of breast and ovarian cancer reveal alternative prevention strategies that may render surgery unnecessary.

11 Sep 2015

Scientists elucidate genetic interaction that may prove key to development, progression of glaucoma

Scientists at the University of California, San Diego School of Medicine have elucidated a genetic interaction that may prove key to the development and progression of glaucoma, a blinding neurodegenerative disease that affects tens of millions of people worldwide and is a leading cause of irreversible blindness.

11 Sep 2015

Hastings Center receives NSF grant for ethical analysis of next-generation prenatal genetic tests

Prenatal testing is changing dramatically. With greatly expanded low-cost genetic tests - some as simple as a maternal blood test - prospective parents will soon be able to learn far more, far earlier, than ever before about their fetuses' medical conditions and risks, and some nonmedical traits.

11 Sep 2015

Professor Hawking to open inaugural Cambridge Rare Disease Summit on 14 September, 2015

Professor Hawking was famously diagnosed with the rare motor neuron disease at 21, and was told science had no answers. He has of course gone on to live a long and productive life, and the Cambridge Rare Disease Summit will discuss how to make this a reality for the 3.5 million other Britons who live with a rare disease.

11 Sep 2015

Genes that may mitigate smoking damage and cancer identified

Smoking has been shown to have drastic consequences for lifespan and disease progression, and it has been suggested that cigarette exposure may impact the risk of death and disease via its acceleration of the aging process. Not all smokers experience early mortality, however, and a small proportion manage to survive to extreme ages.

10 Sep 2015

Nicotine reinforcement demonstrated in study with ‘never-smokers’

In a study with 18 adults who had never smoked, scientists at Johns Hopkins report they have demonstrated one of the earliest steps — nicotine “reinforcement” — in the process of addiction, and shown that some people are far more vulnerable to nicotine addiction than others.

10 Sep 2015

First patient dosed in long term-safety extension study of Resolaris for adult patients with FSHD

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced that the first patient has been dosed in a newly initiated long term-safety extension study of Resolaris for adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare and severe genetic myopathy for which there are currently no approved treatments.

10 Sep 2015

CureVac, IAVI team up to advance development, testing of AIDS vaccines

The non-profit International AIDS Vaccine Initiative (IAVI) and biopharmaceutical company CureVac are partnering to accelerate the development of AIDS vaccines, utilizing novel immunogens developed by IAVI and partners, delivered via CureVac's novel messenger RNA (mRNA) technology.

10 Sep 2015

UF Health Cancer Center — Orlando Health opens Cancer Genetics Center

Patients at high risk for cancer will now have access to their own specialized center with a dedicated oncologist, nurse practitioner and genetic counselor to assist them with their unique health needs.

10 Sep 2015

A new approach to prevent breast and ovarian cancer

Surgery to remove the breasts of women at increased risk of developing breast cancer may not be necessary in the future, according to research published in EBioMedicine.

10 Sep 2015

Researchers use nanopore technology for early detection of colorectal and lung cancers

Using tiny "nanopore" scanners that can detect individual DNA molecules, Professor Amit Meller and colleagues are on the hunt for biological markers in cancer cells that may help clinicians diagnose colorectal and lung cancers at their earliest stages.

10 Sep 2015

Study points to genetic/metabolic factors that make people vulnerable to nicotine addiction

In a study with 18 adults who had never smoked, scientists at Johns Hopkins report they have demonstrated one of the earliest steps — nicotine "reinforcement" — in the process of addiction, and shown that some people are far more vulnerable to nicotine addiction than others.

10 Sep 2015

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

Of the more than 50 known lysosomal storage diseases (LSDs)-rare inherited metabolic disorders-only seven can be treated with approved enzyme-replacement therapies.

10 Sep 2015

Researchers take new line of approach to combat Alzheimer's disease

Today, more than 5.1 million Americans live with Alzheimer's disease, a devastating type of dementia that plagues memory and thinking. That number is expected to triple in the coming decades. Moreover, according to a 2012 survey, Americans fear Alzheimer's more than any other disease.

10 Sep 2015

Dr Tavormina wins IDT award for global warming and methane sinks research

Integrated DNA Technologies (IDT), the world leader in custom oligonucleotide synthesis, awarded the inaugural IDT ISO 14001 Sustainability Award to Dr Patricia Tavormina of the Division of Geological and Planetary Sciences at the California Institute of Technology. Dr Tavormina's research focuses on naturally occurring methane-oxidizing bacteria (MOB), and the role they play in limiting greenhouse gases, which contribute to global warming.

From Integrated DNA Technologies 10 Sep 2015

Smoking may not always shorten life, cause cancer

10 Sep 2015

CRISPR tool streamlines gene editing

Within the past few years, a new technology has made altering genes in plants and animals much easier than before. The tool, called CRISPR/Cas9 or just CRISPR, has spurred a flurry of research that could one day lead to hardier crops and livestock, as well as innovative biomedicines. But along with potential benefits, it raises red flags, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.

10 Sep 2015

Simple stem cell production method shows promise in mice for treating IPF

In a small pilot study, researchers from North Carolina State University have demonstrated a rapid, simple way to generate large numbers of lung stem cells for use in disease treatment. This method of harvesting and growing a patient's own lung stem cells shows promise in mice for treating idiopathic pulmonary fibrosis (IPF), and could one day provide human IPF sufferers with an effective, less invasive method of treatment for their disease.

10 Sep 2015

Riddell, TGen start third year of study to advance concussion treatment with ASU's football program

Riddell, the leader in football helmet technology and innovation, and the Translational Genomics Research Institute, a leader in cutting-edge genomic research, today announced they have begun the third year of a study to advance concussion detection and treatment with the Pac-12's Arizona State University and its Sun Devil football program.

10 Sep 2015

Genetic News and Research

New collaboration may allow researchers to develop potential gene therapies for pediatric diseases

Research: Cancer preventative surgery may not be necessary in the future

Scientists elucidate genetic interaction that may prove key to development, progression of glaucoma

Hastings Center receives NSF grant for ethical analysis of next-generation prenatal genetic tests

Professor Hawking to open inaugural Cambridge Rare Disease Summit on 14 September, 2015

Genes that may mitigate smoking damage and cancer identified

Nicotine reinforcement demonstrated in study with ‘never-smokers’

First patient dosed in long term-safety extension study of Resolaris for adult patients with FSHD

CureVac, IAVI team up to advance development, testing of AIDS vaccines

UF Health Cancer Center — Orlando Health opens Cancer Genetics Center

A new approach to prevent breast and ovarian cancer

Researchers use nanopore technology for early detection of colorectal and lung cancers

Study points to genetic/metabolic factors that make people vulnerable to nicotine addiction

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

Researchers take new line of approach to combat Alzheimer's disease

Dr Tavormina wins IDT award for global warming and methane sinks research

Smoking may not always shorten life, cause cancer

CRISPR tool streamlines gene editing

Simple stem cell production method shows promise in mice for treating IPF

Riddell, TGen start third year of study to advance concussion treatment with ASU's football program

Sequencing & Genomics: Elevating Science and Healthcare eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News